Abbott Challenges Biosimilar Legality
13:55 EDT 25 Jun 2012 | The Big Red Biotech Blog
This from today's Xconomy. Abbott has filed a citizen's petition with the FDA to protect Humira by challenging the notion that the agency can refer to Abbott's Humira BLA filing. Their argument (posted here and here before) is that this would violate..
Original Article: Abbott Challenges Biosimilar Legality
More From BioPortfolio on "Abbott Challenges Biosimilar Legality"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
